Kairos Pharma, Ltd. (KAPA)

NYSEAMERICAN: KAPA · Real-Time Price · USD

0.2900

-0.0051 (-1.73%)

At close: Aug 21, 2026, 4:00 PM EDT

0.2653

-0.0247 (-8.52%)

After-hours: Aug 21, 2026, 8:00 PM EDT

Kairos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7	15	20	-	-	-
Market Cap Growth	-69.04%	-24.29%	-	-	-	-
Enterprise Value	4	9	16	-	-	-
Last Close Price	0.29	0.71	1.52	-	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	1.48	2.33	4.09	-	-	-
P/TBV Ratio	1.64	2.35	4.29	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-	-	-	-0.31	-0.50	-0.34
Net Debt / Equity Ratio	-0.63	-0.71	-0.27	-0.26	-0.13	-0.28
Net Debt / EBITDA Ratio	0.45	0.83	0.58	-0.35	-0.36	-0.17
Quick Ratio	9.91	22.57	1.28	0.04	0.27	0.04
Current Ratio	11.98	27.07	4.20	0.04	0.27	0.04
Return on Equity (ROE)	-113.96%	-97.99%	-192.96%	-	-	-
Return on Assets (ROA)	-66.91%	-56.59%	-43.50%	-107.07%	-39.41%	-307.71%
Return on Capital Employed (ROCE)	-142.10%	-87.90%	-49.10%	119.00%	95.60%	166.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-84.47%	-36.85%	-13.33%	-	-	-
Buyback Yield / Dilution	-46.73%	-62.27%	-9.38%	-1.42%	-11.86%	3.12%

SEC Filings: 10-K · 10-Q